Diabetes drug tested as potential leukemia fighter
NCT ID NCT01750567
Summary
This study tested whether metformin, a common and inexpensive diabetes medication, could help control chronic lymphocytic leukemia (CLL). It involved 37 adults with either relapsed CLL or a specific genetic type of untreated CLL. The goal was to see if taking metformin could slow the disease's progression and delay the need for stronger chemotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.